UFP Technologies CEO Says AJR Move To Dominican Republic Is 'Behind Schedule'
Gross margin rose to 29.4% in the third quarter, but the CEO pointed to 2027 for more AJR transfers while pitching larger acquisitions.
UFP Technologies CEO Mitch Rock told analysts on the company's third-quarter earnings call Wednesday that "we're behind schedule moving AJR activity to the Dominican Republic," with more transfer work now pointed at 2027. UFP, a maker of custom single-use medical device products, reported sales of $172.4 million, up 11.6%.
AJR transfers slip into 2027
Rock said UFP remains committed to finishing the transfers, scaling up operations and delivering the savings it anticipates. Asked by a KeyBanc analyst whether the last programs could move this year, he called AJR a "complex transfer," said customer priorities can shift, and said the company is "looking forward to 27 to complete additional transfer activity."
Chief Financial Officer Ronald Lataille described a continued margin headwind at AJR. High-labor products slated for the Dominican Republic still depend on customer qualification, he said.
Gross margin still rose to 29.4% from 27.7% a year earlier. Rock said the overall AJR business is contributing.
Margins, cash and costs
Asked about 2027, Rock said the company is "comfortable in the portfolio in our range of 28 to 31" and is "settling in at that 29%." Adjusted operating margin was 17.5%, and adjusted earnings per share rose to $2.88. Year to date, sales are up 10.3% to $500.6 million.
Lataille said UFP generated about $38.5 million in cash from operations in the quarter, spent $3.9 million on capital projects and ended with leverage well under one times EBITDA. SG&A expenses rose $4.1 million to $23.2 million, partly from back-office hires, senior management additions and about $800,000 of non-cash equity pay tied partly to duplicate CEO costs. Rock said the duplicate CEO costs will roll off, while added cybersecurity costs are permanent.
Rock said 2026 is a flat-to-down year in robotic surgery, consistent with the quarter's results. Growth came from patient beds and handling, cardiovascular, infection control and orthopedic submarkets.
Bigger deals and a bigger credit line
Rock said UFP is positioning to do more acquisitions, is making progress on several opportunities and is working to expand its credit facility. The current facility lets it borrow at 3.25 times EBITDA, and he said the same playbook would apply at larger scale.
In August UFP bought CI Medical, a medical device printing business. Rock said its 2025 investment in TPI gave it a strong initial position in medical injection molding, and that CI Medical adds printing on molded and extruded plastic parts.
Rock said he is optimistic about 2027, while acknowledging "areas where execution needs to improve."
Sources
- UFP: Q3 Earnings Snapshot – WTOP News — wtop.com
- UFP Technologies Announces Strong Q3 Results – Company Announcement - FT.com — Financial Times
- UFP Technologies GAAP EPS of $2.64 beats by $0.16, revenue of $172.4M beats by $5.39M (UFPT:NASDAQ) — seekingalpha.com
- UFP: Q3 Earnings Snapshot | wusa9.com — Associated Press
- UFP: Q3 Earnings Snapshot | 11alive.com — Associated Press